More than 200 riders and support crew are on the road for the annual Tour de Cure Signature Tour, participants embarking on a 9-day cycling event aiming to raise $2 million for cancer research, support programs and prevention projects Australia-wide.
The Signature Tour started in Canberra on Thursday, 12th March, with cyclists and support crew travelling to Jindabyne on Friday, 13th March.
On Saturday, 14th March, the journey will continue from Jindabyne to Corryong, along the Alpine Way. Motorists can expect to encounter the cyclists and their peloton safety vehicles as they depart at various times in the morning on the road to Thredbo, Khancoban and onwards to Corryong.
Over the course of the journey, riders will cover 1,400km and approximately 20,000m of elevation, cycling through regional towns and communities while raising awareness of cancer prevention and the importance of early detection
Signature Tour Schedule 2026
Day 0: Thursday 12th March – Arrival in Canberra
Day 1: Friday 13th March – Canberra > Jindabyne
Day 2: Saturday 14th March – Jindabyne > Corryong
Day 3: Sunday 15th March – Corryong > Beechworth
Day 4: Monday 16th March – Ballarat > Geelong
Day 5: Tuesday 17th March – Geelong Loop via Torquay
Day 6: Wednesday 18th March – Devonport > Cradle Mountain
Day 7: Thursday 19th March – Cradle Mountain > Launceston
Day 8: Friday 20th March – Launceston > Swansea
Day 9: Saturday 21st March – Swansea > Hobart
Marking its 20th year, the 2026 Signature Tour has grown from humble beginnings into one of Australia’s most inspiring and impactful charity cycling events and Tour de Cure’s single biggest event fundraiser. Over two decades, Tour de Cure has raised more than $158 million, funded more than 1,220 cancer research, prevention programs and support projects including research that’s contributed to 231 world-class scientific breakthroughs.
CEO of Tour de Cure, David Mann, said this milestone reflects the organisation’s long-standing commitment to funding impactful cancer research and support services.
“Reaching our 20th year of Signature Tour is an incredible milestone for Tour de Cure and a testament to the passion and commitment of our community, riders, volunteers and supporters. Our Signature Tour is an extraordinary example of courage and purpose. At Tour de Cure, we are inspired by people who turn their personal cancer experience and ambitions into action that helps others. Every dollar raised will help fund vital cancer research, prevention and support programs, giving more Australians the chance to live healthier, cancer-free lives.” said David Mann.
Mark Beretta OAM, Tour de Cure rider and Board Member, and sport broadcaster, will undertake his 17th consecutive Signature Tour this year. “I keep coming back because of the incredible work Tour de Cure is doing, funding research that I’ve seen first-hand change outcomes and save lives. The Tour de Cure family is a fantastic and supportive group focused on providing researchers with the money they need to push further in beating all forms of cancer. The support we receive from Australians, not just over the 9-days of the ride, but year-round, is extraordinary. The cause means even more to me now having lost my father to cancer in September 2025, and my mum battling stage 4 ovarian cancer.”
To Donate and find more information, visit the website here.
